The therapeutic effect of GAS6 in remyelination is dependent upon Tyro3

Author:

Asadian Negar1ORCID,Aprico Andrea1,Chen Moore2,Yuen Daniel2,Johnston Angus P. R.2,Kilpatrick Trevor J.1,Binder Michele D.1ORCID

Affiliation:

1. The Florey Institute of Neuroscience and Mental Health Parkville Victoria Australia

2. Monash Institute of Pharmaceutical Sciences, Monash University Parkville Victoria Australia

Abstract

AbstractMultiple sclerosis is an autoimmune disease of the central nervous system (CNS) characterized by demyelination, axonal damage and, for the majority of people, a decline in neurological function in the long‐term. Remyelination could assist in the protection of axons and their functional recovery, but such therapies are not, as yet, available. The TAM (Tyro3, Axl, and MERTK) receptor ligand GAS6 potentiates myelination in vitro and promotes recovery in pre‐clinical models of MS. However, it has remained unclear which TAM receptor is responsible for transducing this effect and whether post‐translational modification of GAS6 is required. In this study, we show that the promotion of myelination requires post‐translational modification of the GLA domain of GAS6 via vitamin K‐dependent γ‐carboxylation. We also confirmed that the intracerebroventricular provision of GAS6 for 2 weeks to demyelinated wild‐type (WT) mice challenged with cuprizone increased the density of myelinated axons in the corpus callosum by over 2‐fold compared with vehicle control. Conversely, the provision of GAS6 to Tyro3 KO mice did not significantly improve the density of myelinated axons. The improvement in remyelination following the provision of GAS6 to WT mice was also accompanied by an increased density of CC1+ve mature oligodendrocytes compared with vehicle control, whereas this improvement was not observed in the absence of Tyro3. This effect occurs independent of any influence on microglial activation. This work therefore establishes that the remyelinative activity of GAS6 is dependent on Tyro3 and includes potentiation of oligodendrocyte numbers.

Funder

National Health and Medical Research Council

Australian Government

Trish Multiple Sclerosis Research Foundation

State Government of Victoria

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3